Companion Animal Health Market Size, Share and Growth Outlook, 2026

Companion Animal Health Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Companion Animal Health Market size is forecast to increase from $31.09 Billion in 2026 to $68.61 Billion in 2034 at a CAGR of 10.4% between 2026 and 2034.

The Companion Animal Health market report provides detailed analysis and outlook of Companion Animal Health segments including By Product Category (Therapeutics, Diagnostics, Digital Health and Medical Devices ), By Therapeutic Indication (Infectious Diseases, Dermatology and Allergies, Pain and Inflammation Management, Endocrine and Metabolic Disorders, Oncology, Cardiology), By Animal Type (Dogs, Cats, Horses, Other Small Companion Animals), By Distribution Channel (Veterinary Hospitals and Specialty Clinics, Retail Pharmacies and Pet Stores, Online Pharmacies and E-Commerce Platforms) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Companion Animal Health Industry Overview

Digital Health Technologies Advancing Early Disease Detection in Companion Animals

The companion animal health industry is increasingly focused on preventive care, digital diagnostics, and early disease intervention. A significant development in veterinary cardiology emerged through a strategic collaboration between Boehringer Ingelheim and Eko Health Inc. The partnership integrates advanced canine cardiology algorithms with digital stethoscopes and AI-powered clear-listening software. This combined platform enables veterinary practitioners to detect subtle heart murmurs, early cardiac remodeling, and respiratory abnormalities during routine wellness examinations. Earlier identification of cardiovascular and pulmonary disorders supports timely intervention and improved disease-management pathways for companion animals.

Large-Scale Biobanking Initiatives Supporting Precision Veterinary Medicine

The growing adoption of precision medicine is driving investment in longitudinal research programs and genomic data collection. Mars Inc. continued expansion of the Mars Petcare Biobank, a large-scale initiative designed to follow up to 20,000 healthy dogs and cats over a decade. The program systematically collects biological samples, lifestyle information, and complete genomic sequencing data to identify early indicators of chronic diseases before clinical symptoms emerge. By making full-genome datasets available to global scientific communities, the initiative supports collaborative veterinary research, biomarker discovery, and development of personalized healthcare approaches for companion animals.

Expansion of Innovative Therapeutics Strengthening Veterinary Treatment Options

Product innovation remains a major growth driver across companion animal healthcare. Several advanced therapies have expanded treatment possibilities for common and complex canine conditions. Laverdia from Anivive Lifesciences became the first oral tablet treatment containing verdinexor for canine lymphoma, addressing a significant unmet need in veterinary oncology. Vetmedin from Boehringer Ingelheim received clearance for delaying the onset of congestive heart failure in dogs diagnosed with preclinical myxomatous mitral valve disease. Pegasus Laboratories introduced KBroVet, a potassium bromide chewable tablet designed for long-term seizure management in dogs affected by idiopathic epilepsy. Additionally, MSD Animal Health expanded the availability of Numelvi (atinvicitinib), a highly selective second-generation Janus Kinase 1 inhibitor authorized for the treatment of severe pruritus and skin barrier dysfunction associated with canine atopic dermatitis.

Alternative Nutrition and Sustainable Pet Food Innovations

Nutritional innovation is creating new opportunities within companion animal health and wellness. Biotechnology company Meatly introduced Chick Bites for dogs, representing the first cultivated lab-grown meat pet food approved for retail sale. The product reflects increasing industry interest in alternative protein sources and environmentally sustainable pet nutrition solutions. Cultivated meat technologies are being explored as a means to reduce dependence on conventional livestock production while providing nutritionally viable food options for companion animals.

Companion Animal Health Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Companion Animal Health market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Zoetis Inc., Boehringer Ingelheim International GmbH, Merck Animal Health (MSD Animal Health), Elanco Animal Health Incorporated, IDEXX Laboratories, Inc., Mars, Incorporated, Virbac S.A., Ceva Santé Animale, Vetoquinol S.A., Dechra Pharmaceuticals PLC. The Companion Animal Health market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Companion Animal Health industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Companion Animal Health Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Companion Animal Health companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Companion Animal Health markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Companion Animal Health Market Competitive Benchmarking and Company Analysis

Leading companies in Companion Animal Health industry include- Zoetis Inc., Boehringer Ingelheim International GmbH, Merck Animal Health (MSD Animal Health), Elanco Animal Health Incorporated, IDEXX Laboratories, Inc., Mars, Incorporated, Virbac S.A., Ceva Santé Animale, Vetoquinol S.A., Dechra Pharmaceuticals PLC. The Companion Animal Health market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Companion Animal Health Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Companion Animal Health market remains one of the strongest-performing segments in the country.
The US Companion Animal Health Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Companion Animal Health market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Companion Animal Health industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Companion Animal Health markets

Canada's strong Companion Animal Health sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Companion Animal Health market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Companion Animal Health Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Companion Animal Health market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Companion Animal Health population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Companion Animal Health industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Companion Animal Health market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Companion Animal Health sales through 2034

France Companion Animal Health companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Companion Animal Health Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Companion Animal Health distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Companion Animal Health Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Companion Animal Health market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Companion Animal Health industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Companion Animal Health industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Companion Animal Health Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Companion Animal Health market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Companion Animal Health market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Companion Animal Health Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Companion Animal Health Market Segmentation

By Product Category
Therapeutics
Diagnostics
Digital Health and Medical Devices
By Therapeutic Indication
Infectious Diseases
Dermatology and Allergies
Pain and Inflammation Management
Endocrine and Metabolic Disorders
Oncology
Cardiology
By Animal Type
Dogs
Cats
Horses
Other Small Companion Animals
By Distribution Channel
Veterinary Hospitals and Specialty Clinics
Retail Pharmacies and Pet Stores
Online Pharmacies and E-Commerce Platforms

Top Companies in Companion Animal Health Industry

Zoetis Inc.
Boehringer Ingelheim International GmbH
Merck Animal Health (MSD Animal Health)
Elanco Animal Health Incorporated
IDEXX Laboratories, Inc.
Mars, Incorporated
Virbac S.A.
Ceva Santé Animale
Vetoquinol S.A.
Dechra Pharmaceuticals PLC

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025